Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND

NCT06954155 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Stroke

Interventions

DRUG: Tenecteplase (0.25mg/kg)
DRUG: Standard medical treatment

Sponsor

Beijing Tiantan Hospital